Company'sBrussels office will also house its Benelux operations
New report suggests market will almost double in five years
A plan for guiding decisions about a product's distribution channel is particularly relevant for orphan drugs, rare diseases or specialty medicines
Much more needs to be done to address the problem of effective communications with stakeholders and adequate information for patients affected
There's growing sense of responsibility in the orphan drug market, but the market remains under-exploited by companies
An early commitment to communications planning in rare diseases is worth the risk
Backs site for patients affected by pancreatic neuroendocrine tumours (PNET)
Collaborates with Eurordis on multimedia education campaign
Orphan diseases represent one of the most exciting and emotive areas in modern medicine and need a communications strategy that covers a spectrum of issues
1
